On September 18, CFMEE rose 4.83% in regular trading, trading at HKD 367.4 per share, with turnover of HKD 13.73 million. The stock has sustained upward momentum following its H1 earnings release and management guidance on capacity expansion.
The company reported H1 revenue of RMB 1.106 billion, up 68.95% year-over-year, and attributable net profit of RMB 281 million, up 98.13%. PCB direct imaging equipment revenue reached RMB 880 million, surging 85.4%, while gross margin improved from 40.5% to 42.5%. Operating cash flow swung to a net inflow of RMB 326 million from an outflow of RMB 102 million a year earlier. At the September 14 earnings briefing, Chairman Cheng Zhuo stated that high-end PCB equipment order deliveries remain robust in H2, advanced packaging equipment is entering verification and deployment, and the Phase-Two production base — with designed capacity over twice that of Phase One — will enter full ramp-up in H2. Over the past 90 days, 13 institutions have issued ratings, with 11 assigning buy ratings and an average target price of RMB 519.23.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments